Insulet (PODD) Asset Writedowns and Impairment (2010 - 2026)
Insulet (PODD) reported Asset Writedowns and Impairment of $300000.0 for Q1 2026, down 93.62% on a YoY basis from $4.7 million in Q1 2025, and up 200.0% quarter-over-quarter from $100000.0 in Q3 2025.
Insulet (PODD) Asset Writedowns and Impairment (2010 - 2026) Analysis & Trends
Insulet has reported Asset Writedowns and Impairment for 17 years, with the latest figure at $300000.0 in Q1 2026.
- For the quarter ending Q1 2026, Asset Writedowns and Impairment fell 93.62% year-over-year to $300000.0; the trailing twelve-month figure through Mar 2026 stood at $5.5 million (up 71.88% YoY), and the FY2024 full-year result was -$200000.0, down 108.7% from the prior year.
- Asset Writedowns and Impairment for Q1 2026 stood at $300000.0, up from $100000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $4.7 million in Q1 2025, with the low at -$900000.0 in Q4 2024.
- Historically, Asset Writedowns and Impairment has averaged $780000.0 across 5 years, with a median of $800000.0 in 2022.
- Annual changes were most pronounced in 2022 — Asset Writedowns and Impairment soared 450.0% — and 2024, when it plunged 550.0%.
- Insulet's Asset Writedowns and Impairment stood at $1.1 million in 2022, then slumped by 81.82% to $200000.0 in 2023, then sank by 550.0% to -$900000.0 in 2024, then jumped by 111.11% to $100000.0 in 2025, then surged by 200.0% to $300000.0 in 2026.
- The last three Asset Writedowns and Impairment figures came in at $300000.0 (Q1 2026), $100000.0 (Q3 2025), and $400000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Insulet | 10.20 Bn | 9.72 Bn | 529.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 300,000.00 |
| Mar 31, 2026 | 300,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Mar 31, 2025 | 4.70 Mn |
| Mar 31, 2025 | 4.70 Mn |
| Dec 31, 2024 | -900,000.00 |
| Dec 31, 2024 | -900,000.00 |
| Jun 30, 2024 | -600,000.00 |
| Jun 30, 2024 | -600,000.00 |
| Mar 31, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.20 Mn |
| Dec 31, 2023 | 200,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 800,000.00 |
| Jun 30, 2023 | 800,000.00 |